Dicerna Pharmaceuticals Inc Contracts & Agreements

Agreement and Plan of Merger, dated November 17, 2021, by and among Dicerna Pharmaceuticals, Inc., Novo Nordisk A/S, and NNUS New Research, Inc (Filed With SEC on November 18, 2021)

Royalty Acquisition Agreement by and between the Company and Royalty Pharma PLC, dated as of April 8, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Transition and Separation Agreement by and between the Company and Ralf Rosskamp, dated as of April 15, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and John Green, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and Bob D. Brown, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and James B. Weissman, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and Ralf Rosskamp, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and Robert Ciappenelli, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Amendment No. 1 to Employment Agreement by and between the Company and Regina Paglia, dated as of April 14, 2021 (Filed With SEC on May 6, 2021)

Sales Agreement, dated as of May 6, 2021, between the Registrant and Cowen and Company, LLC (Filed With SEC on May 6, 2021)

Employment Agreement by and between the Company and (Filed With SEC on November 5, 2020)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2014 Performance Incentive Plan (Filed With SEC on November 5, 2020)

Form of Restricted Stock Unit Award Agreement under the Amended and Restated 2016 Inducement Plan (Filed With SEC on November 5, 2020)

Amended and Restated Employment Agreement by and between the Company and Regina DeTore Paglia, dated as of February 21, 2020 (Filed With SEC on August 6, 2020)

Collaboration and License Agreement by and between the Company and Alnylam Pharmaceuticals, Inc., dated as of April 3, 2020 (Filed With SEC on August 6, 2020)

Patent Cross-License Agreement by and between the Company and Alnylam Pharmaceuticals, Inc., dated as of April 3, 2020 (Filed With SEC on August 6, 2020)

First Amendment to Collaboration and License Agreement by and between the Company and F. Hoffman-La Roche Inc., dated as of May 22, 2020 (Filed With SEC on August 6, 2020)

Second Amendment to Collaboration and License Agreement, by and between the Company and F. Hoffman-La Roche Inc., dated as of June 22, 2020 (Filed With SEC on August 6, 2020)

Amendment to Indenture of Lease by and between the Company and HCP/King 75 Hayden LLC, dated as of July 1, 2020 (Filed With SEC on August 6, 2020)

Second Amendment to Lease Agreement by and between the Company and Western Office Portfolio Property Owner LLC, dated as of July 8, 2020 (Filed With SEC on August 6, 2020)

Transition Agreement dated as of April 16, 2020, by and between the Company and Ralf Rosskamp (Filed With SEC on May 7, 2020)

Employment Agreement by and between the Company and Douglas Pagn, dated as of May 26, 2020 (Filed With SEC on May 7, 2020)

Description of Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on February 28, 2020)

Amended and Restated Employment Agreement dated as of February 25, 2020 by and between the Company and John B. Green (Filed With SEC on February 28, 2020)

Amended and Restated Employment Agreement dated as of February 24, 2020 by and between the Company and James B. Weissman (Filed With SEC on February 28, 2020)

Amended and Restated Employment Agreement dated as of February 21, 2020 by and between the Company and Bob. D. Brown (Filed With SEC on February 28, 2020)

Amended and Restated Employment Agreement dated as of February 21, 2020 by and between the Company and Douglas M. Fambrough, III (Filed With SEC on February 28, 2020)

Amended and Restated Employment Agreement dated as of February 26, 2020 by and between the Company and Ralf Rosskamp (Filed With SEC on February 28, 2020)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on January 13, 2020)

Form of Restricted Stock Unit Grant Notice (Filed With SEC on January 13, 2020)

Lease Agreement between the Company and Western Office Portfolio Property Owner LLC, dated as of August 26, 2019 (Filed With SEC on November 7, 2019)

Alexion Share Issuance Agreement, dated October 22, 2018, by and between the Company and Alexion Pharma Holding Unlimited Company (Filed With SEC on March 13, 2019)

Lilly Share Issuance Agreement, dated October 25, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on March 13, 2019)

Additional Target Agreement, dated December 31, 2018, by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on March 13, 2019)

Collaborative Research and License Agreement, dated October 22, 2018, by and between the Company and Alexion Pharma Holding Unlimited Company (Filed With SEC on March 13, 2019)

Collaboration and License Agreement, dated October 25, 2018, by and between the Company and Eli Lilly and Company (Filed With SEC on March 13, 2019)

Underwriting Agreement dated September 6, 2018 by and among Dicerna Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Leerink Partners LLC (Filed With SEC on September 11, 2018)

Confidential Settlement Agreement and General Release, dated as of April 18, 2018, between the Company and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 8, 2018)

Share Issuance Agreement, dated as of April 20, 2018, between the Company and Alnylam Pharmaceuticals, Inc (Filed With SEC on August 8, 2018)

Collaborative Research and License Agreement, dated October 27, 2017, by and between the Company and Boehringer Ingelheim International GmbH (Filed With SEC on March 8, 2018)

Underwriting Agreement dated December 14, 2017 by and among Dicerna Pharmaceuticals, Inc., Stifel, Nicolaus & Company, Incorporated and Evercore Group L.L.C (Filed With SEC on December 18, 2017)

Form of Pre-Funded Warrant (Filed With SEC on December 18, 2017)

Form of First Amendment to Amended and Restated Registration Rights Agreement (Filed With SEC on December 18, 2017)

Letter Agreement entered into on December 13, 2017 by and between Dicerna Pharmaceuticals, Inc. and the holders of its redeemable convertible preferred stock (Filed With SEC on December 14, 2017)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2017)

See Restrictive Legends on Reverse Side of Certificate Incorporated Under the Laws of the State of Delaware (Filed With SEC on March 30, 2017)

REDEEMABLE CONVERTIBLE PREFERREDSTOCK PURCHASE AGREEMENT AMONG DICERNA PHARMACEUTICALS, INC. AND THE INVESTORS NAMED HEREIN DATED AS OF MARCH 30, 2017 (Filed With SEC on March 30, 2017)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT BY AND AMONG DICERNAPHARMACEUTICALS, INC. AND THE INVESTORS NAMED HEREIN DATED AS OF , 2017 (Filed With SEC on March 30, 2017)

[Remainder of Page Intentionally Left Blank] -2- (Filed With SEC on March 30, 2017)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 7, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on August 4, 2016)

DICERNA PHARMACEUTICALS, INC. 2014 PERFORMANCE INCENTIVE PLAN TERMS AND CONDITIONS OF INCENTIVE STOCK OPTION (Filed With SEC on March 10, 2016)

DICERNA PHARMACEUTICALS, INC. 2014 PERFORMANCE INCENTIVE PLAN TERMS AND CONDITIONS OF NONQUALIFIED STOCK OPTION (Filed With SEC on March 10, 2016)

******* (Filed With SEC on March 10, 2016)

DICERNA PHARMACEUTICALS, INC. 2016 INDUCEMENT PLAN (Filed With SEC on March 10, 2016)

DICERNA PHARMACEUTICALS, INC. 2016 INDUCEMENT PLAN TERMS AND CONDITIONS OF INDUCEMENT STOCK OPTION (Filed With SEC on March 10, 2016)

DICERNA PHARMACEUTICALS, INC. AMENDED AND RESTATED 2014 PERFORMANCE INCENTIVE PLAN (Filed With SEC on July 7, 2015)

2,750,000 Shares DICERNA PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on May 22, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2015)

LICENSEAGREEMENT by and between DICERNA PHARMACEUTICALS, INC., on the one hand, and PROTIVA BIOTHERAPEUTICS INC. and TEKMIRA PHARMACEUTICALS CORPORATION on the other hand... (Filed With SEC on March 12, 2015)

DEVELOPMENT AND SUPPLY AGREEMENT By and Among PROTIVA BIOTHERAPEUTICS INC. And TEKMIRA PHARMACEUTICALS CORPORATION ON THE ONE HAND, And DICERNA PHARMACEUTICALS, INC. ON THE OTHER... (Filed With SEC on March 12, 2015)

87 CAMBRIDGEPARK DRIVE CAMBRIDGE,MASSACHUSETTS LEASE SUMMARY SHEET (Filed With SEC on November 6, 2014)

RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 29, 2014)

[] Shares of Common Stock DICERNA PHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on January 28, 2014)

DICERNA PHARMACEUTICALS, INC. 2014 PERFORMANCE INCENTIVE PLAN (Filed With SEC on January 28, 2014)

DICERNA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 28, 2014)

DICERNA PHARMACEUTICALS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on January 28, 2014)

LOAN AND SECURITY AGREEMENT (Filed With SEC on January 28, 2014)

RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 28, 2014)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on January 28, 2014)

COMMERCIAL LICENCE AGREEMENT (Filed With SEC on January 28, 2014)

LEASE AGREEMENT (Filed With SEC on January 28, 2014)

[Company Letterhead] (Filed With SEC on January 28, 2014)

FORM OF DICERNA PHARMACEUTICALS, INC. 2014 PERFORMANCE INCENTIVE PLAN (Filed With SEC on January 17, 2014)

FORM OF DICERNA PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on January 17, 2014)

DICERNA PHARMACEUTICALS, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on January 17, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on January 17, 2014)

RESEARCH COLLABORATION AND LICENSE AGREEMENT BETWEEN DICERNA PHARMACEUTICALS,INC. AND KYOWA HAKKO KIRINCO., LTD. December 21, 2009 (Filed With SEC on January 17, 2014)

FORM OF WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on December 31, 2013)

WARRANT AGREEMENT To Purchase Shares of the Series A Preferred Stock of DICERNA PHARMACEUTICALS, INC. Dated as of March 25, 2009 (the Effective Date) (Filed With SEC on December 31, 2013)

WARRANT AGREEMENT To Purchase Shares of the Series B Preferred Stock of DICERNA PHARMACEUTICALS, INC. Dated as of July 6, 2011 (the Effective Date) (Filed With SEC on December 31, 2013)

FORM OF WARRANT TO PURCHASE PREFERRED STOCK (Filed With SEC on December 31, 2013)

AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. THIRD AMENDED AND RESTATED 2007 EMPLOYEE, DIRECTOR AND CONSULTANT STOCK PLAN (Filed With SEC on December 31, 2013)

FORM OF RESTRICTED STOCK AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

FORM OF INCENTIVE STOCK OPTION AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. 2010 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITY INCENTIVE PLAN (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. Stock Option Grant Notice Stock Option Grant under the Companys 2010 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on December 31, 2013)

RESTRICTED STOCK AGREEMENT DICERNA PHARMACEUTICALS, INC. (Filed With SEC on December 31, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 31, 2013)

EMPLOYMENTAGREEMENT (Filed With SEC on December 31, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. 480 Arsenal Street Building 1, Suite 120 Watertown, MA 02472 (Filed With SEC on December 31, 2013)

DICERNA PHARMACEUTICALS, INC. 480 Arsenal Street Building 1, Suite 120 Watertown, MA 02472 February 28, 2011 (Filed With SEC on December 31, 2013)

TRANSITION AGREEMENT (Filed With SEC on December 31, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on December 31, 2013)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 31, 2013)

COMMERCIAL LICENCE AGREEMENT (Filed With SEC on December 31, 2013)

LEASE AGREEMENT (Filed With SEC on December 31, 2013)

Category

Industry

Companies

Contracts

Dicerna Pharmaceuticals Inc Contracts & Agreements